Osteoblastic niche supports the growth of quiescent multiple myeloma cells

Blood

Volumn 123, Issue 14, 2014, Pages 2204-2208

  Chen, Zheng ^a   Orlowski, Robert Z ^b   Wang, Michael ^b   Kwak, Larry ^b   McCarty, Nami ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; DYE; OSTEOCALCIN; OSTEOGENIC PROTEIN 1; ORGANIC COMPOUND; PKH 2 DYE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL CULTURE; CELL CYCLE; CELL HETEROGENEITY; CELL TRACKING; CONTROLLED STUDY; ENGRAFTMENT; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOUSE; MULTIPLE MYELOMA; MYELOMA CELL; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; STEM CELL NICHE; TUMOR GROWTH; ANIMAL; CANCER STEM CELL; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; METHODOLOGY; NONOBESE DIABETIC MOUSE; PATHOLOGY; SCID MOUSE;

ANIMALS; CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; CELL TRACKING; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; MULTIPLE MYELOMA; NEOPLASTIC STEM CELLS; ORGANIC CHEMICALS; OSTEOBLASTS; STEM CELL NICHE;

EID: 84902115879     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-07-517136     Document Type: Article

References (8)

1. Traycoff CM, Kosak ST, Grigsby S, Srour EF. Evaluation of ex vivo expansion potential of cord blood and bone marrow hematopoietic progenitor cells using cell tracking and limiting dilution analysis. Blood. 1995;85(8):2059- 2068.
2. Huang S, Law P, Francis K, Palsson BO, Ho AD. Symmetry of initial cell divisions among primitive hematopoietic progenitors is independent of ontogenic age and regulatory molecules. Blood. 1999;94(8):2595-2604. (Pubitemid 29477288)
3. Lanzkron SM, Collector MI, Sharkis SJ. Hematopoietic stem cell tracking in vivo: a comparison of short-term and long-term repopulating cells. Blood. 1999;93(6):1916-1921. (Pubitemid 29128493)
4. Noll JE, Williams SA, Purton LE, Zannettino AC. Tug of war in the haematopoietic stem cell niche: do myeloma plasma cells compete for the HSC niche? Blood Cancer J. 2012;2:e91.
5. Matsui W, Huff CA, Wang Q, et al. Characterization of clonogenic multiple myeloma cells. Blood. 2004;103(6):2332-2336. (Pubitemid 38326254)
6. Li L, Bhatia R. Stem cell quiescence. Clin Cancer Res. 2011;17(15):4936-4941.
7. Jung HJ, Chen Z, Fayad L, et al. Bortezomib-resistant nuclear factor κB expression in stem-like cells in mantle cell lymphoma. Exp Hematol. 2012;40(2):107-118, e2.
8. Jung HJ, Chen Z, McCarty N. Stem-like tumor cells confer drug resistant properties to mantle cell lymphoma. Leuk Lymphoma. 2011;52(6): 1066-1079.